Cellular prion protein in blood platelets associates with both lipid rafts and the cytoskeleton

Summary

The recently shown transmissibility of variant Creutzfeldt-Jakob disease (vCJD) by blood transfusion emphasises the need for better understanding of the cellular prion protein (PrPc) in blood. A substantial amount of cell-associated PrPc in blood resides in platelets. Platelet activation leads to up-regulation of PrPc on the platelet surface and its release on exosomes and microparticles. The sub-cellular localisation and function of platelet PrPc, however, is poorly understood. In the present study, we investigated the association of PrPc with platelet lipid rafts and the platelet cytoskeleton. Immuno-fluorescence microscopy showed that the signals of PrPc and P-selectin, both of which occupy intracellular alpha granules, were separated on the membrane, suggesting organisation in different membrane domains. A flotation assay of platelet lysates demonstrated that a relatively small portion of platelet PrPc floats with lipid rafts, regardless of platelet activation status. This was reversed by depolymerisation of the platelet cytoskeleton, which led to flotation of most platelet PrPc, suggesting that interactions with the cytoskeleton prevent flotation of PrPc rafts. This association of PrPc with the platelet cytoskeleton was confirmed by its presence in both the isolated membrane skeleton and actin cytoskeleton. Platelet activation significantly increased the amount of PrPc associated with the cytoskeleton. Our results indicate that the localisation of PrPc in platelets is complex, with the majority of PrPc present within platelet lipid rafts linked to the platelet cytoskeleton. This localisation places PrPc in a position where it can interact with proteins involved in platelet signalling and eventually with vCJD prions.

Keywords

Blood platelets - cytoskeleton - lipid rafts - prion protein - PrPc

• References

• 1 MacGregor I, Hope J, Barnard G. et al. Application of a time-resolved fluoroimmunoassay for the analysis of normal prion protein in human blood and its components. Vox Sang 1999; 77: 88-96.
• 2 Barclay GR, Hope J, Birkett CR. et al. Distribution of cell-associated prion protein in normal adult blood determined by flow cytometry. Br J Haematol 1999; 107: 804-814.
• 3 Holada K, Mondoro TH, Muller J. et al. Increased expression of phosphatidylinositol-specific phospholipase C resistant prion proteins on the surface of activated platelets. Br J Haematol 1998; 103: 276-282.
• 4 Starke R, Harrison P, Mackie I. et al. The expression of prion protein (PrP(C)) in the megakaryocyte lineage. J Thromb Haemost 2005; 03: 1266-1273.
• 5 Holada K, Glierova H, Simak J. et al. Expression of cellular prion protein on platelets from patients with gray platelet or Hermansky-Pudlak syndrome and the protein’s association with alpha-granules. Haematologica 2006; 91: 1126-1129.
• 6 Robertson C, Booth SA, Beniac DR. et al. Cellular prion protein is released on exosomes from activated platelets. Blood 2006; 107: 3907-3911.
• 7 Zivny JH, Gelderman MP, Xu F. et al. Reduced erythroid cell and erythropoietin production in response to acute anemia in prion protein-deficient (Prnp−/−) mice. Blood Cells Mol Dis. 2007 ((please complete reference)).
• 8 Zhang CC, Steele AD, Lindquist S. et al. Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal. Proc Natl Acad Sci USA 2006; 103: 2184-2189.
• 9 Westergard L, Christensen HM, Harris DA. The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim Biophys Acta 2007; 1772: 629-644.
• 10 Rachidi W, Vilette D, Guiraud P. et al. Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J Biol Chem 2003; 278: 9064-9072.
• 11 Milhavet O, Lehmann S. Oxidative stress and the prion protein in transmissible spongiform encephalopathies. Brain Res Brain Res Rev 2002; 38: 328-339.
• 12 Watt NT, Hooper NM. The prion protein and neuronal zinc homeostasis. Trends Biochem Sci 2003; 28: 406-410.
• 13 Collinge J, Whittington MA, Sidle KC. et al. Prion protein is necessary for normal synaptic function. Nature 1994; 370: 295-297.
• 14 Mouillet-Richard S, Ermonval M, Chebassier C. et al. Signal transduction through prion protein. Science 2000; 289: 1925-1928.
• 15 Montixi C, Langlet C, Bernard AM. et al. Engagement of T cell receptor triggers its recruitment to lowdensity detergent-insoluble membrane domains. Embo J 1998; 17: 5334-5348.
• 16 Horejsi V, Drbal K, Cebecauer M. et al. GPI-microdomains: a role in signalling via immunoreceptors. Immunol Today 1999; 20: 356-361.
• 17 Tsui-Pierchala BA, Encinas M, Milbrandt J. et al. Lipid rafts in neuronal signaling and function. Trends Neurosci 2002; 25: 412-417.
• 18 Bodin S, Tronchere H, Payrastre B. Lipid rafts are critical membrane domains in blood platelet activation processes. Biochim Biophys Acta 2003; 1610: 247-257.
• 19 Israels SJ, McMillan-Ward EM. Platelet tetraspanin complexes and their association with lipid rafts. Thromb Haemost 2007; 98: 1081-1087.
• 20 Dorahy DJ, Burns GF. Active Lyn protein tyrosine kinase is selectively enriched within membrane microdomains of resting platelets. Biochem J 1998; 333: 373-379.
• 21 Dorahy DJ, Lincz LF, Meldrum CJ. et al. Biochemical isolation of a membrane microdomain from resting platelets highly enriched in the plasma membrane glycoprotein CD36. Biochem J 1996; 319: 67-72.
• 22 Wonerow P, Obergfell A, Wilde JI. et al. Differential role of glycolipid-enriched membrane domains in glycoprotein VI- and integrin-mediated phospholipase Cgamma2 regulation in platelets. Biochem J 2002; 364: 755-765.
• 23 Sardjono CT, Harbour SN, Yip JC. et al. Palmitoylation at Cys595 is essential for PECAM-1 localisation into membrane microdomains and for efficient PECAM-1-mediated cytoprotection. Thromb Haemost 2006; 96: 756-766.
• 24 van Lier M, Verhoef S, Cauwenberghs S. et al. Role of membrane cholesterol in platelet calcium signalling in response to VWF and collagen under stasis and flow. Thromb Haemost 2008; 99: 1068-1078.
• 25 Taraboulos A, Scott M, Semenov A. et al. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol 1995; 129: 121-132.
• 26 Kaneko K, Vey M, Scott M. et al. COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform. Proc Natl Acad Sci USA 1997; 94: 2333-2338.
• 27 Holada K, Simak J, Vostal JG. Transmission of BSE by blood transfusion. Lancet 2000; 356: 1772.
• 28 Baglia FA, Shrimpton CN, Lopez JA. et al. The glycoprotein Ib-IX-V complex mediates localization of factor XI to lipid rafts on the platelet membrane. J Biol Chem 2003; 278: 21744-21750.
• 29 Schuck S, Honsho M, Ekroos K. et al. Resistance of cell membranes to different detergents. Proc Natl Acad Sci USA 2003; 100: 5795-5800.
• 30 Fox JE, Boyles JK, Berndt MC. et al. Identification of a membrane skeleton in platelets. J Cell Biol 1988; 106: 1525-1538.
• 31 Hoffmeister KM, Falet H, Toker A. et al. Mechanisms of cold-induced platelet actin assembly. J Biol Chem 2001; 276: 24751-24759.
• 32 Bodin S, Soulet C, Tronchere H. et al. Integrin-dependent interaction of lipid rafts with the actin cytoskeleton in activated human platelets. J Cell Sci 2005; 118: 759-769.
• 33 Ezumi Y, Kodama K, Uchiyama T. et al. Constitutive and functional association of the platelet collagen receptor glycoprotein VI-Fc receptor gamma-chain complex with membrane rafts. Blood 2002; 99: 3250-3255.
• 34 Brown DA, London E. Structure and origin of ordered lipid domains in biological membranes. J Membr Biol 1998; 164: 103-114.
• 35 Brdicka T, Pavlistova D, Leo A. et al. Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation. J Exp Med 2000; 191: 1591-1604.
• 36 Drevot P, Langlet C, Guo XJ. et al. TCR signal initiation machinery is pre-assembled and activated in a subset of membrane rafts. Embo J 2002; 21: 1899-1908.
• 37 Chamberlain LH. Detergents as tools for the purification and classification of lipid rafts. FEBS Lett 2004; 559: 1-5.
• 38 Holada K, Dyr JE, Koubek K. et al. Characterization of platelet antigen for CD45RA monoclonal antibodies. Immunobiology 1995; 192: 272-277.
• 39 Locke D, Chen H, Liu Y. et al. Lipid rafts orchestrate signaling by the platelet receptor glycoprotein VI. J Biol Chem 2002; 277: 18801-18809.
• 40 Maurice P, Waeckel L, Pires V. et al. The platelet receptor for type III collagen (TIIICBP) is present in platelet membrane lipid microdomains (rafts). Histochem Cell Biol 2006; 125: 407-417.
• 41 Bodin S, Giuriato S, Ragab J. et al. Production of phosphatidylinositol 3,4,5-trisphosphate and phosphatidic acid in platelet rafts: evidence for a critical role of cholesterol-enriched domains in human platelet activation. Biochemistry 2001; 40: 15290-15299.
• 42 Nieznanski K, Nieznanska H, Skowronek KJ. et al. Direct interaction between prion protein and tubulin. Biochem Biophys Res Commun 2005; 334: 403-411.
• 43 Petrakis S, Sklaviadis T. Identification of proteins with high affinity for refolded and native PrPC. Proteomics 2006; 06: 6476-6484.
• 44 Holada K, Simak J, Risitano AM. et al. Activated platelets of patients with paroxysmal nocturnal hemoglobinuria express cellular prion protein. Blood 2002; 100: 341-343.
• 45 Keshet GI, Bar-Peled O, Yaffe D. et al. The cellular prion protein colocalizes with the dystroglycan complex in the brain. J Neurochem 2000; 75: 1889-1897.
• 46 Cerecedo D, Martinez-Rojas D, Chavez O. et al. Platelet adhesion: structural and functional diversity of short dystrophin and utrophins in the formation of dystrophin-associated-protein complexes related to actin dynamics. Thromb Haemost 2005; 94: 1203-1212.
• 47 Holada K, Vostal JG, Theisen PW. et al. Scrapie infectivity in hamster blood is not associated with platelets. J Virol 2002; 76: 4649-4650.
• 48 Cervenakova L, Yakovleva O, McKenzie C. et al. Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion 2003; 43: 1687-1694.
• 49 Holada K, Vostal JG. Different levels of prion protein (PrPc) expression on hamster, mouse and human blood cells. Br J Haematol 2000; 110: 472-480.
• 50 Jones M, Peden AH, Prowse CV. et al. In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc. J Pathol 2007; 213: 21-26.